Veren (Delisted)
VRN
6.01
0.00
0.00%
Veren (Delisted)
US · VRN
#2346 by market cap
Listed 1970
6.01
0.00
0.00%
Live - 5344 symbols - heartbeat 247s ago
· 2026-10-07 19:54
- Market cap
- 3.68B
- P/E (TTM)i
- 19.45
- P/Bi
- 0.78
- EPSi
- 0.31
- Div yieldi
- 5.32%
- 52W posi
- --
Reader sentiment
Are you bullish or bearish on VRN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -0.19, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +24.52% YoY
Margins
- Gross margin
- 56.44%
- Operating margin
- 24.38%
- Net margin
- 6.19%
Key ratios & quality
- Enterprise valuei
- 6.17B
- Altman Z-Scorei
- -0.19
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.86B | 3.32B | 2.88B | 1.49B | 2.83B | 3.51B | 3.19B | 3.97B |
| Gross profit | 1.09B | -1.99B | 1.60B | 763.10M | 2.01B | 2.60B | 2.23B | 2.49B |
| Selling & admin expenses | 160.00M | 167.90M | 116.80M | 80.00M | 120.70M | 117.20M | 165.20M | 131.10M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -42.40M | -3.17B | 604.30M | 4.60M | 1.15B | 1.72B | 1.09B | 1.08B |
| Pretax profit | -23.60M | -3.56B | -1.19B | -3.15B | 3.16B | 1.56B | 1.05B | 343.70M |
| Tax | 100.40M | -938.50M | -159.00M | -627.60M | 799.70M | 415.10M | 253.70M | 59.80M |
| Net profit | -124.00M | -2.62B | -1.03B | -2.52B | 2.36B | 1.48B | 570.30M | 273.30M |
| Basic EPS | 0 | -5 | -2 | -5 | 4 | 3 | 1 | 0 |
| Diluted EPS | -0.23 | -4.77 | -1.89 | -4.76 | 4.11 | 2.60 | 1.04 | 0.44 |
| Line item | 2023-09 | 2023-12 | 2024-03 | 2024-06 | 2024-09 | 2024-12 |
|---|---|---|---|---|---|---|
| Revenue | 908.70M | 861.40M | 1.02B | -- | 919.90M | 981.80M |
| Gross profit | 650.20M | 592.60M | 648.40M | 698.80M | 546.70M | 597.20M |
| Selling & admin expenses | 39.30M | 41.20M | 40.80M | 46.30M | 19.00M | 25.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 350.90M | 268.80M | 268.00M | 333.30M | 222.50M | 245.30M |
| Pretax profit | 179.60M | 391.10M | -515.10M | 334.40M | 365.10M | 159.30M |
| Tax | 46.00M | 88.50M | -116.20M | 73.50M | 87.90M | 14.60M |
| Net profit | -809.90M | 951.20M | -411.70M | 261.00M | 277.20M | 146.80M |
| Basic EPS | -2 | 2 | -1 | 0 | 0 | 0 |
| Diluted EPS | -1.52 | 1.74 | -0.66 | 0.42 | 0.45 | 0.24 |
Balance sheet
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 509.30M | 586.60M | 631.50M | 278.70M | 410.90M | 989.20M | 1.05B | 676.80M |
| Cash & ST investments | 62.40M | 15.30M | 56.90M | 8.80M | 13.50M | 289.90M | 17.30M | 17.10M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 16.01B | 12.73B | 10.09B | 6.65B | 9.17B | 9.49B | 12.78B | 11.75B |
| Total current liabilities | 863.50M | 688.60M | 775.30M | 669.20M | 1.03B | 1.24B | 1.37B | 1.19B |
| Short-term debt | 67.20M | 103.20M | 232.30M | 248.00M | 303.60M | 563.60M | 420.50M | 573.90M |
| Long-term debt | 4.05B | 4.18B | 2.70B | 2.04B | 1.69B | 902.80M | 3.19B | 1.94B |
| Total liabilities | 6,842,400,000.00 | 6,117,600,000.00 | 4,749,100,000.00 | 3,823,100,000.00 | 3,765,900,000.00 | 2,993,000,000.00 | 5,908,200,000.00 | 4,990,000,000.00 |
| Total equity | 9.16B | 6.61B | 5.34B | 2.82B | 5.41B | 6.49B | 6.87B | 6.76B |
| Retained earnings | -7.75B | -10.57B | -11.64B | -14.17B | -11.85B | -10.56B | -10.20B | -10.21B |
| Line item | 2023-09 | 2023-12 | 2024-03 | 2024-06 | 2024-09 | 2024-12 |
|---|---|---|---|---|---|---|
| Total current assets | 1.62B | 1.05B | 1.38B | 630.50M | 1.09B | 676.80M |
| Cash & ST investments | 45.60M | 17.30M | 21.80M | 5.80M | 8.20M | 17.10M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 10.37B | 12.78B | 12.04B | 11.34B | 11.51B | 11.75B |
| Total current liabilities | 1.25B | 1.37B | 1.33B | 1.29B | 1.24B | 1.19B |
| Short-term debt | 410.70M | 420.50M | 425.40M | 529.50M | 524.30M | 573.90M |
| Long-term debt | 2.56B | 3.19B | 3.20B | 2.35B | 2.29B | 1.94B |
| Total liabilities | 4,660,600,000.00 | 5,908,200,000.00 | 5,659,600,000.00 | 4,811,500,000.00 | 4,793,700,000.00 | 4,990,000,000.00 |
| Total equity | 5.71B | 6.87B | 6.38B | 6.52B | 6.72B | 6.76B |
| Retained earnings | -11.09B | -10.20B | -10.69B | -10.50B | -10.29B | -10.21B |
Cash flow
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.72B | 1.75B | 1.74B | 860.50M | 1.50B | 2.19B | 2.20B | 2.11B |
| Depreciation & amortization | 1.74B | 5.28B | 2.71B | 712.70M | 786.10M | 951.70M | 1.07B | 1.34B |
| Free cash flow | -136.00M | -69.80M | 436.70M | 161.70M | 819.70M | 1.16B | 975.20M | 524.00M |
| Dividends paid | -197.70M | -198.50M | -22.00M | -9.40M | -47.80M | -200.60M | -211.90M | -284.60M |
| Stock buybacks / issuance | -2.60M | -1.70M | -123.40M | -12.90M | -17.50M | -294.20M | 129.80M | -101.90M |
| Ending cash balance | 62.40M | 15.30M | 56.90M | 8.80M | 13.50M | 289.90M | 17.30M | 17.10M |
| Line item | 2023-09 | 2023-12 | 2024-03 | 2024-06 | 2024-09 | 2024-12 |
|---|---|---|---|---|---|---|
| Operating cash flow | 648.90M | 611.30M | 411.20M | 625.80M | 561.70M | 513.10M |
| Depreciation & amortization | 320.90M | 247.90M | 344.10M | 322.10M | 338.10M | 334.00M |
| Free cash flow | 297.00M | 319.20M | -6.70M | 238.10M | 157.00M | 135.60M |
| Dividends paid | -71.70M | -68.30M | -71.30M | -71.70M | -70.90M | -70.70M |
| Stock buybacks / issuance | -124.50M | 395.80M | -10.00M | -42.60M | -14.30M | -35.00M |
| Ending cash balance | 45.60M | 17.30M | 21.80M | 5.80M | 8.20M | 17.10M |
Returns & efficiency
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -1.32 | -33.18 | -17.29 | -61.72 | 57.46 | 24.93 | 8.54 | 4.01 |
| ROA %i | -0.77 | -18.21 | -9.06 | -30.11 | 29.89 | 15.90 | 5.12 | 2.23 |
| ROIC %i | -0.04 | -20.47 | -9.15 | -35.77 | 38.11 | 19.71 | 7.15 | 4.25 |
| 5-year avg ROE %i | -2.44 | -9.42 | -13.97 | -24.59 | -11.21 | -5.96 | 2.39 | 6.65 |
| EBIT margin %i | 4.20 | -86.15 | -30.41 | -179.05 | 100.45 | 42.14 | 33.07 | 12.19 |
| FCF / sales %i | -- | -- | 13.00 | 9.48 | 25.31 | 25.36 | 27.35 | 11.87 |
| Current ratioi | 0.59 | 0.85 | 0.81 | 0.42 | 0.40 | 0.80 | 0.76 | 0.57 |
| Quick ratioi | 0.51 | 0.49 | 0.46 | 0.31 | 0.32 | 0.50 | 0.35 | 0.35 |
| Debt / assetsi | 25.96 | 33.91 | 30.58 | 36.35 | 23.02 | 16.50 | 29.05 | 26.09 |
| LT debt / equityi | 44.61 | 63.71 | 53.42 | 76.81 | 33.45 | 15.43 | 47.91 | 36.85 |
| Interest coveragei | 0.85 | -18.28 | -6.00 | -32.27 | 36.59 | 29.92 | 9.36 | 2.77 |
| Revenue CAGR (3Y) %i | -7.51 | 11.80 | 9.65 | -20.01 | -6.11 | 5.52 | 27.87 | 10.88 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -51.29 |
| FCF CAGR (3Y) %i | -- | -- | 7.56 | -- | -- | 38.68 | 82.02 | -13.86 |
| Line item | 2023-09 | 2023-12 | 2024-03 | 2024-06 | 2024-09 | 2024-12 |
|---|---|---|---|---|---|---|
| ROE %i | -13.60 | 8.54 | -0.89 | -0.14 | 17.34 | 4.01 |
| ROA %i | -8.45 | 5.12 | -0.53 | -0.08 | 9.85 | 2.23 |
| ROIC %i | -9.30 | 7.15 | 0.75 | 1.46 | 13.35 | 4.25 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.55 | 33.07 | 11.78 | 13.73 | 17.92 | 12.19 |
| FCF / sales %i | 23.71 | 27.35 | 20.98 | 19.82 | 16.47 | 11.87 |
| Current ratioi | 1.29 | 0.76 | 1.03 | 0.49 | 0.88 | 0.57 |
| Quick ratioi | 0.41 | 0.35 | 0.32 | 0.30 | 0.27 | 0.35 |
| Debt / assetsi | 29.48 | 29.05 | 30.97 | 26.22 | 25.15 | 26.09 |
| LT debt / equityi | 46.35 | 47.91 | 51.78 | 37.44 | 35.30 | 36.85 |
| Interest coveragei | 3.01 | 9.36 | 2.70 | 2.98 | 3.96 | 2.77 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Region
Canada107.53%
Purchased product sales3.59%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.